Story thread · 2 reports / 2 sources

HSE to consider covering cost of Friedreich's Ataxia drug

rte.ie · 15h · first report

HSE to consider covering cost of Friedreich's Ataxia drug

The HSE Drugs Group will meet later today to give further consideration on whether to cover the drug Skyclarys, which can slow the progression of Friedreich's Ataxia.

The coverage

  1. Treatment for Friedreich's ataxia should not be funded by HSE, drugs group recommends

    thejournal.ie · 3h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.